From: miR194 hypomethylation regulates coronary artery disease pathogenesis
 | control (n = 5) | CAD (n = 5) | P value |
---|---|---|---|
Age (years) | 57.00 ± 8.15 | 66.4 ± 5.32 | 0.063 |
Gender (male%) | 2 (40%) | 3 (60%) | Â |
Smoking history[n (%)] | 1 (25%) | 2 (40%) | Â |
Hypertention [n (%)] | 1 (20%) | 4 (80%) | Â |
Diabetes [n (%)] | 2 (20%) | 4(80%) | Â |
TC (mmol/L) | 2.75 ± 0.48 | 3.97 ± 0.82 | 0.021 |
TG (mmol/L) | 1.26 ± 1.35 | 2.33 ± 1.47 | 0.263 |
LDL-C (mmol/L) | 2.55 ± 0.51 | 3.07 ± 0.97 | 0.140 |
HDL-C (mmol/L) | 1.39 ± 0.42 | 1.02 ± 0.16 | 0.096 |
Aspirin administration [n (%)] | 0 (0%) | 4 (80%) | Â |
Statins administration [n (%)] | 0 (0%) | 3 (60%) | Â |
Gensini scores | 1.3 ± 1.1 | 59.6 ± 8.0 | 0.000 |